Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen GSH Bio-tech is a high-tech biotechnology company specializing in the research, development, and industrial-scale production of high-value APIs and intermediates through enzymatic synthesis. The company leverages its proprietary biocatalysis platform to produce key molecules such as Glutathione (GSH), Nicotinamide Mononucleotide (NMN), and Citicoline Sodium with high purity and environmental efficiency. Headquartered in Shenzhen with a large-scale manufacturing base in Anhui, GSH Bio-tech serves the global pharmaceutical, nutraceutical, and cosmetic industries. Their business model focuses on replacing traditional chemical synthesis with green, enzyme-driven processes to reduce environmental impact and production costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen GSH Bio-tech.